Accelerating Early Development Clinical Research in NASH

ProSciento is a leading provider of clinical research services in NASH (nonalcoholic steatohepatitis), drawing on almost a decade of direct clinical research experience and 17 years of complementary work in diabetes, obesity and other metabolic diseases.

We provide clients customized strategies to accelerate their NASH clinical research programs, addressing the complexities of biomarker selection, patient access, study enrollment, timeline adherence, clinical site experience, and access to protocol-required methodologies. This comprehensive approach includes our NASH hub & spokes clinical trial management platform, which integrates multi-site trial design and logistics, patient pre-screening strategies, and specialized methodologies to successfully deliver a clinical NASH program.

ProSciento’s Approach to Navigating the Complexities of NASH Clinical Research:

Selection and use of targeted NASH biomarkers and advanced methodologies
IRB-approved protocol and registry designed to substantially improve enrollment outcomes in NASH clinical trials
Science-driven logistics management for multi-site studies utilizing specialized methodologies